Grünenthal uses its own and third-party cookies to improve the browsing experience, offer personalized content and improve its services. We use analytics scripts which set tracking cookie, but we will activate these services only with your consent. If you press the button “Accept”, you consent to the use of these analytics scripts.

You can withdraw your consent at any time. To do so, please modify your configurations on this website by following this link to our privacy statement with the configuration options:
Go to settings



Strategic therapeutic areas

We focus on four key therapeutic areas that we want to address with life-changing innovations: peripheral neuropathic pain, chronic post-surgical pain, chronic lower back pain, and osteoarthritis. We take a holistic and solution-agnostic approach to pursuing breakthrough treatments for these pain conditions, exploring all possible technologies and modalities.

Our in-house capabilities are focused around critical and differentiating areas such as target identification with a strong emphasis on human and clinical validation, translational science as well as disease understanding. Above and beyond these particularly critical success factors, we can cover every step in the development of an innovative medicine.

At the same time, we are committed to enter into strategic partnerships with innovative players from across industry and academia who share our passion to shape the field and foster the development of meaningful therapies. And alongside our pursuit of these four key areas, we’re also looking for partners who are eager to team up with us in the development of therapeutic solutions for patients with fibromyalgia, complex regional pain syndrome, migraine and peri-surgical pain.

Our therapeutic areas